Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion - Teleflex (NYSE:TFX)

Teleflex inks deals to sell 3 businesses for $2B

Needham analysts said Teleflex’s inability to secure a price above the low end of their expectations could reflect “the continued poor performance of UroLift.”

Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion - Teleflex (NYSE:TFX)

WAYNE, Pa., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced it has entered into definitive agreements to sell the company's Acute Care, Interventional Urology and OEM businesses to two buyers, Intersurgical® Ltd with respect to Acute Care and Interventional Urology, and Montagu and Kohlberg with respect to OEM, for a combined total of $2.03 billion in cash, su…

Teleflex to sell trio of business lines in deals totalling over $2bn

Teleflex is selling its acute care, interventional urology, and original equipment manufacturer (OEM) businesses in two separate deals totalling over $2bn as part of the company’s broader portfolio optimisation strategy.The post Teleflex to sell trio of business lines in deals totalling over $2bn appeared first on Medical Device Network.

Teleflex to sell three of its businesses for $2.03 billion

The Entire Business World on a Single Page with the Web's Most Comprehensive One-Stop Finance News Hub.